Literature DB >> 11857623

Testing normality of fetal DNA concentration in maternal plasma at 10-12 completed weeks' gestation: a preliminary approach to a new marker for genetic screening.

Antonio Farina1, Elisabetta Caramelli, Manuela Concu, Akihiko Sekizawa, Roberto Ruggeri, Luciano Bovicelli, Nicola Rizzo, Paolo Carinci.   

Abstract

OBJECTIVES: To test the distribution of fetal DNA in maternal plasma expressed as gen/eq in a population of normal pregnancies.
METHODS: Peripheral blood samples were obtained from 63 women (85% > or =35 years of age at delivery) bearing a euploid male fetus. Each patient underwent chorionic villus sampling (CVS) for karyotype analysis and/or beta thalassemia screening. Ultrasound scanning was used to determine gestational age. At 10-12 weeks' gestation, a peripheral blood sample was collected followed by CVS. To detect the Y chromosome specific sequences (SRY) quantitative polymerase chain reaction (PCR) analysis was used. Normal distribution of the data was tested by means of the Kolmogorov-Smirnov (KS) test. A Symmetry test (reliability p>0.05) was used to evaluate the reliability of the median.
RESULTS: Only after natural logarithmic transformation did the data display a normal distribution. The median value of fetal DNA was 23.3 gen/eq (range 2.08-195), interquartile range 18.57-45.4. A Pearson test showed a significant correlation between gestational age and fetal DNA concentration (r=0.25, p=0.045).
CONCLUSION: The present finding is a preliminary step towards a possible integration of fetal DNA with other variables (biochemical and/or ultrasound). It may serve to improve the discrimination of the screening for genetic diseases in the first trimester. Because of the relatively high dispersion, adjustments for possible covariates would appear to be necessary in further studies. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857623     DOI: 10.1002/pd.262

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases.

Authors:  Munis Dundar; Asli Subasioglu Uzak; Murat Erdogan; Yagut Akbarova
Journal:  EPMA J       Date:  2011-05-06       Impact factor: 6.543

2.  NIPT Technique Based on the Use of Long Chimeric DNA Reads.

Authors:  Vera Belova; Daria Plakhina; Sergey Evfratov; Kirill Tsukanov; Gennady Khvorykh; Alexander Rakitko; Alexander Konoplyannikov; Valery Ilinsky; Denis Rebrikov; Dmitriy Korostin
Journal:  Genes (Basel)       Date:  2020-05-26       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.